Dtsch Med Wochenschr 2010; 135(38): 1870
DOI: 10.1055/s-0030-1263329
Pro & Contra | Commentary
Hämatologie, Infektiologie
© Georg Thieme Verlag KG Stuttgart · New York

Pilzprophylaxe bei hämatologischen Patienten: pro

Prophylaxis of fungal infections in haematological patients: proB. Glaß1
  • 1Abteilung Hämatologie und Stammzelltransplantation, Asklepios-Klinik St. Georg, Hamburg
Further Information

Publication History

Publication Date:
14 September 2010 (online)

Literatur

  • 1 Cornely O. et al . Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies.  Haematologica. 2009;  94 113-122
  • 2 Cornely O A. et al . Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.  N Engl J Med. 2007;  356 348-359
  • 3 Marr K A. et al . Invasive aspergillosis in allogeneic stem cell transplant recipients.  Blood. 2003;  100 4358-4366
  • 4 Park B J. et al .Comparison of zygomycosis and fusariosis to invasive aspergillosis (IA) among transplant recipients reporting to TRANSNET. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,. Washington; 2004: Abstract M-666
  • 5 Slavin M A. et al . Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation.  J Infect Dis. 1995;  171 1545-1552
  • 6 Ullman A J. et al . Posaconazole or fluconazole for prophylaxis in severe graft versus host disease.  N Engl J Med. 2007;  356 335-347

Prof. Dr. Bertram Glaß

Abteilung Hämatologie und Stammzelltransplantation
Asklepios Klinik St. Georg

Lohmühlenstr. 5

20099 Hamburg

Phone: 040/181885-3537

Fax: 040/181885-4226

Email: b.glass@asklepios.com